Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kenvue: A Look At The Johnson Spinoff
05:59pm, Friday, 05'th May 2023
Kenvue Inc. has been spun off from Johnson & Johnson in a rather large IPO. The spinoff was well-received by the market, being the world's largest pure-play consumer health play.
ETFs to Bet on the Successful Debut of Kenvue
12:55pm, Friday, 05'th May 2023
Kenvue is the world's largest pure-play consumer health company by revenue, and makes well-known products, including Tylenol, Neutrogena, Listerine, Johnson???s', Band-Aid, Aveeno, Zyrtec and Nicorett
Kenvue stock slips on second day of trading
12:16pm, Friday, 05'th May 2023
Yahoo Finance Live's Julie Hyman discusses the decline in stock for Kenvue.
Kenvue CEO looks to brand, product innovation to drive growth after IPO
09:40am, Friday, 05'th May 2023
Kenvue CEO Thibaut Mongon said the spinoff's portfolio of brands, which includes Band-Aid, Tylenol and Neutrogena, has "ample opportunity" to grow.
Kenvue Stock Surges On Trading Debut
09:00am, Friday, 05'th May 2023
Kenvue Inc. is defensive and resilient to macro shocks. The company owns a portfolio of well-established brands.
J&J's Kenvue: Unlocking Value in a Stagnant Market
06:13pm, Thursday, 04'th May 2023
2023 has been a pretty slow year as far as initial public offerings go, but pharmaceutical giant Johnson & Johnson ( JNJ , Financial) bucked the trend on Thursday by offering its consumer health divis
Johnson & Johnson Spinoff Kenvue Valued at $41 Billion in IPO
03:25pm, Thursday, 04'th May 2023
Johnson & Johnson's consumer healthcare spinoff has made the biggest U.S. initial public offering (IPO) since 2021. Kenvue, which includes Band-Aid and several other well-known consumer brands that ha
Kenvue IPO: Profitable Company, Expensive Stock
03:02pm, Thursday, 04'th May 2023
At its expected valuation, KVUE looks fully valued and does not provide investors with much upside potential.
J&J's consumer health spinoff Kenvue begins trading at $25.53 per share
02:05pm, Thursday, 04'th May 2023
J&J's consumer health IPO Kenvue opens to the NYSE.
Kenvue stock opens 16% above IPO, valuing the company at $47.7 billion
12:50pm, Thursday, 04'th May 2023
Kenvue Inc. shares KVUE, +16.16% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.55% spinoff, with consumer brands including Tylenol, Band-Aid and Listerine, saw it'
J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
12:49pm, Thursday, 04'th May 2023
Kenvue's debut is the biggest U.S. IPO since EV maker Rivian went public in 2021.
J&J spinoff Kenvue goes public
12:13pm, Thursday, 04'th May 2023
Kenvue CEO Thibaut Mongon joins 'Squawk on the Street' to discuss the company's IPO, which is the largest U.S. IPO since November 2021.
Johnson & Johnson spinoff Kenvue prices largest IPO since 2021
11:52am, Thursday, 04'th May 2023
Johnson & Johnson (NYSE:JNJ)'s consumer health unit Kenvue Inc just priced the biggest US IPO since 2021, in a spot of welcome news for capital markets. The spinoff is expected to achieve a valuatio
KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading
10:53am, Thursday, 04'th May 2023
Kenvue (NYSE: KVUE ) stock is set to start trading today as the company completes its spinoff from Johnson & Johnson (NYSE: JNJ ). Let's go over all of the details investors need to know about Kenvue
J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion
10:15am, Thursday, 04'th May 2023
Kenvue, which owns brands including Tylenol, Band-Aid, and Neutrogena, will begin trading Thursday. Shares were priced higher than an earlier range.
